Physician profile
Conner C Mcdaniel
NPI 1407243959
$2,381.66
in general payments reported to CMS, 2019-2025
19 companies · $282 in 2025
The $282 reported for 2025 was more than what a typical Surgical Critical Care provider received nationally (typical 2025 total: $234).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $107 · 2021: $234 · 2022: $1,376 · 2023: $338 · 2024: $43.64 · 2025: $282.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $664.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $664.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $1,230.67 | 2022 | |
| Depuy Synthes Sales INC. | $178.54 | 2023-2025 | Trumatch, Matrixrib |
| Davol INC. | $148.07 | 2023 | Arista Ah Flexitip |
| Abbvie INC. | $137.38 | 2022-2025 | |
| Stryker Corporation | $108.40 | 2021 | |
| Kci USA, INC. | $98.42 | 2021-2023 | Prevena |
| Allergan, INC. | $89.96 | 2022 | |
| Janssen Pharmaceuticals, INC | $65.14 | 2021-2022 | |
| Csl Behring | $63.21 | 2020 | |
| Ambu INC. | $57.50 | 2025 | |
| Octapharma USA, INC. | $34.08 | 2025 | Fibryga |
| Acera Surgical, INC. | $28.43 | 2025 | Restrata Wound Matrix |
| Pfizer INC. | $27.74 | 2020-2021 | |
| Kerecis Limited | $26.03 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Becton, Dickinson and Company | $24.51 | 2024 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $18.88 | 2023 | Andexxa |
| Medtronic, INC. | $16.26 | 2023 | Signia |
| Mallinckrodt Hospital Products INC. | $14.74 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $13.70 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Conner Mcdaniel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.